492 research outputs found

    Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data

    No full text
    Jens U. Rüggeberg, Michael S. Gold, José-Maria Bayas, Michael D. Blum, Jan Bonhoeffer, Sheila Friedlander, Glacus de Souza Brito, Ulrich Heininger, Babatunde Imoukhuede, Ali Khamesipour, Michel Erlewyn-Lajeunesse, Susana Martin, Mika Mäkelä, Patricia Nell, Vitali Pool, Nick Simpson and The Brighton Collaboration Anaphylaxis Working Grouphttp://www.elsevier.com/wps/find/journaldescription.cws_home/30521/description#descriptio

    Papillomavirus-Infektionen

    No full text

    Infektionen des Kehlkopfs und der Trachea

    No full text

    Pneumonia

    No full text

    Influenza-associated myositis in children

    Get PDF
    BACKGROUND: Influenza-associated myositis (IAM) is an infrequent and poorly known complication of influenza virus infection in children. The aim of this study was to describe five cases of IAM and to review the literature on IAM in children. PATIENTS AND METHODS: We conducted a retrospective analysis of cases of IAM diagnosed at two university children's hospitals in Switzerland during two consecutive influenza seasons. Findings were compared with 39 individual case reports and five publications summarizing an additional 272 cases identified by a medical online library (MEDLINE) search. RESULTS: Overall, 316 cases were analyzed. IAM typically occurred in school-aged children with a 2:1 male predominance. Influenza B and A viruses were identified in 76% and 24% of cases, respectively. The median interval between onset of influenza and onset of IAM was 3 days (range 0-18). The calf muscles were involved alone or together with other muscle groups in 69% and 31% of cases, respectively. Blood creatine phosphokinase (CPK) concentration was invariably elevated. Median duration to clinical recovery was 3 days (range 1-30). Rhabdomyolysis occurred in ten of 316 patients (3%), was more common in girls (80%), more often associated with influenza A (86%), and led to renal failure in eight patients (80%). CONCLUSION: Clinical and laboratory findings of IAM are highly characteristic and allow a rapid diagnosis during the influenza season

    Diagnosing tuberculosis

    No full text

    Mycoplasma

    No full text

    Pertussis : an old disease that is still with us

    No full text
    Our knowledge of pathogenesis, clinical presentation and prevention of pertussis has improved substantially over recent years. We now better understand the function of long-known virulence factors for Bordetella pertussis, and genome sequencing has identified a multitude of new proteins; their functions are yet to be elucidated. Furthermore, improved diagnostic tools have revealed the broad spectrum of disease, and new insights into the host's immune response have been gained. Finally, the development, evaluation, licensing and implementation of several new acellular pertussis vaccines with high acceptance have changed the epidemiology of pertussis in many countries (i.e. a shift towards an increasing burden of disease in adolescent persons and adults). These developments are likely to have great impact on the daily practice not only of paediatricians, but also of general practitioners, internists, gynaecologists and many other specialists in adolescent and adult medicine. The present review provides an update on recent progress

    Anthrax

    No full text
    corecore